# Cradle wins public competition to design a cancer-binding protein

> Cradle, a protein engineering company, won a public competition to design a protein that binds tightly to a cancer target, beating 130 teams and more than 1,000 submissions.

- Status: reported (One outlet, not independently verified yet.)
- Topic: Research
- Published: 2026-11-05T21:11:17+00:00
- Updated: 2026-11-05T21:11:17+00:00
- Web page: https://ai-news.ikangai.com/story/cradle-wins-public-competition-to-design-a-cancer-binding-protein/
- Seen in: The AI Report
- Change: other (Other)

Cradle, a protein engineering company, won a public competition to design a protein that binds tightly to a cancer target. The win came out of 130 teams and more than 1,000 submissions. Eli Bixby, Head of Machine Learning at Cradle, described the method to The AI Report. His point is about data: in biology, most of the information needed to design a useful protein has not been collected yet.

Cradle's software is used by pharma, agriculture and industrial biotech teams. The models do not only generate answers. They recommend which experiments a scientist should run next, learn from the results, and repeat. Bixby said it usually takes two or three rounds of this loop to hit a customer's targets.

The Report presents the competition win as a good proof point for Cradle's technology.

## Why it matters

The result suggests that iterative, experiment-guided AI design can produce competitive protein candidates, which matters for pharma and biotech teams weighing protein engineering software.

---

AI wrote this summary from the sources listed, and nobody reviewed it individually before publication. Check the original source before you rely on it.

Cite as: IKANGAI AI News, "Cradle wins public competition to design a cancer-binding protein", 2026-11-05, https://ai-news.ikangai.com/story/cradle-wins-public-competition-to-design-a-cancer-binding-protein/
